DZ Bank Discount Zert BNR 31.12.2.../ DE000DQ1TBH7 /
28.05.2024 8:17:21 | Изменение0.00 | Бид13:05:01 | Предложение13:05:01 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
39.08EUR | 0.00% | 39.11 Величина цены спроса: 5,000 |
39.13 Величина цены предложения: 5,000 |
BRENNTAG SE NA O.N. | - EUR | 31.12.2024 | Call |
GlobeNewswire
14:01
ParaZero Received a Purchase Order for its Advanced Safety Systems for UAE-based Manufacturer of Hea...
GlobeNewswire
14:01
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at A...
GlobeNewswire
14:00
Spectral AI to Participate in Benzinga’s “AI Unleashed: Exploring the Possibilities” Virtual Event
GlobeNewswire
14:00
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study
GlobeNewswire
14:00
Invitation to ScottsMiracle-Gro’s “Meet the Management” Investor Day in Marysville, Ohio
GlobeNewswire
14:00
Marotta Controls Earns Exceptional Small Business Performance Award from Lockheed Martin for the Sec...
Newsfile Corp
14:00
MineHub Appoints New Chief Financial Officer; Announces Timing of Fiscal Fourth Quarter and Annual 2...
Newsfile Corp
14:00
Gaia to Present at Water Tower Research's Inaugural Consumer Products Virtual Investor Conference Ju...
GlobeNewswire
14:00
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility
GlobeNewswire
14:00
Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
14:00
Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
GlobeNewswire
14:00
Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharma...
GlobeNewswire
14:00
Solowin Announces Strategic Partnership with MaiCapital to Expand Virtual Asset Allocation Opportuni...
GlobeNewswire
14:00
Gorilla Technology and SINTRONES Partner to Develop In-Vehicle AI Computing Capabilities
GlobeNewswire
14:00
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница